METASTATIC COLORECTAL CANCER MCRC WITH WILD-TYPE RAS: THE CONTINUATION OF ANTI-EGFR THERAPY WITH A CHANGE OF CHEMOTHERAPY AFTER DISEASE PROGRESSION. Вопр. онкол. [Internet]. 2017 Mar. 1 [cited 2026 Oct. 14];63(3):456-60. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/729